Skip to main content
. Author manuscript; available in PMC: 2015 Nov 23.
Published in final edited form as: Lung Cancer. 2014 Sep 17;86(2):190–194. doi: 10.1016/j.lungcan.2014.09.007

Table 1.

Patient characteristics.

ALK n (%) EGFR n (%) Fisher's exact test p-value
Sex
 F 22 (73%) 71 (73%) 1.000
 M 8 (27%) 26 (27%)
Smoking history
 No 23 (77%) 70 (72%) 0.814
 Yes 7 (23%) 27 (28%)
Stage I 3 (10%) 23 (24%)
Stage II 1 (3%) 3 (3%) Stage I vs Stage
Stage III 8 (27%) 10 (10%) II + III + IV: 0.125
Stage IV 18 (60%) 61 (63%)
ALK EGFR Wilcoxon rank-sum test
n (%) n (%) p-value

Age, median (range) 49.5 (36.0, 76.2) 63.4 (32.6, 89.9) <0.001
HHS Vulnerability Disclosure